Yahoo Finance Neuroendoscopy Devices Market is anticipated to have an effective CAGR of 7.6% during the period of 2022-2032 | Future Market Insights, Inc.
During the forecast period, the global neuroendoscopy devices market is expected to flourish due to an increase in brain tumour cases around the world. The neuroendoscopic devices market will benefit from the rising incidence of brain tumours across the globe, as well as the technological advancements in neuroendoscopic devices
NEWARK, Del, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The neuroendoscopy devices market is expected to escalate at a CAGR of 7.6% from USD 165.0 Million in 2022 to USD 343.2 Million through 2032.
COVID-19 has moderately affected the neuroendoscopy market, these devices are used for treating conditions of the central nervous system, and as elective surgeries have been postponed, neuroendoscopy has been less utilized than usual and therefore has experienced a decrease in investment.
Globally increasing brain tumour incidences and technological advancements in neuroendoscopic devices will lead to growth opportunities for the neuroendoscopic devices market.
In 2021, after delayed elective procedures are completed, and vaccines are available, the neuroendoscope devices market is expected to have a strong performance as patients feel safer about completing delayed screenings.
As per the American Society of Clinical Oncology (ASCO), an estimated 23,820 cases of brain tumors were reported in the United States in 2019. In addition, brain tumors account for close to 90% of all primary central nervous system tumors, thereby creating growth opportunities for the neuroendoscopy devices market, and about 3,720 pediatric tumour cases were reported in 2019.
Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14926
A major restraint to neuroendoscopy device market growth is the high cost of procedure & equipment.
In addition to an increase in the number of brain tumor cases around the globe, numerous risk factors, such as radiation exposure and family medical history, are expected to influence the global market for neuroendoscopy devices. Accordingly, the global neuroendoscopy devices market is projected to experience significant growth as brain cancer incidence increases.
Increasing prevalence of pituitary tumors throughout Europe is expected to drive the neuro endoscopy market in Europe. A number of major companies such as B Braun and Karl Storz are located in North America, which is driving regional growth. Meanwhile, increasing incidence of acute pediatric brain tumors will further expand market size. Furthermore, the rising demand for minimally invasive procedures among the population also contributes to the dominance of North America market shares during the analysis period.
In addition to growing brain tumor prevalences as well as increasing non-invasive biopsies at the medical facilities, Asia Pacific neuroendoscopy market growth will be strongly augmented by escalating healthcare expenditures of rapidly developing economies including India, Vietnam, and others.
People above the age of 65 years are particularly at risk of developing brain tumors, in fact, glioblastoma is the most common primary brain tumor prevalent among the geriatric population. The growing number of elderly people across countries like India and China will lead to significant market growth in neuroendoscopy devices.
KEY TAKEAWAYS:
The neuroendoscopy devices market is predicted to develop at a CAGR of 7.5% in the intraventricular surgery section of the surgery type category.
In the United States, the neuroendoscopy devices market is estimated to reach US$ 122.5 million by 2032, rising at a CAGR of 7.4% throughout the forecast period.
By 2032, the neuroendoscopy devices market in the United Kingdom is expected to be valued US$ 14.1 million, with a CAGR of 6.3% through 2032.
With a CAGR of 6.9% throughout the forecast period, China is expected to reach a market size of US$ 28.4 million in neuroendoscopy devices market by 2032.
By 2032, the neuroendoscopy devices market in Japan is estimated to be worth US$ 20.0 million, growing at an annual rate of 5.9% through 2032.
With a CAGR of 5.2% throughout the forecast period, South Korea is predicted to reach a market size of US$ 12.5 million in neuroendoscopy devices market by 2032.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14926
COMPETITIVE LANDSCAPE:
Companies that have developed new products to increase their market share among consumers are also adopted by leading companies. It is these strategies that have led to the development of the neuroendoscopy devices market.
Globally, B. Braun, Aesculap, and Karl Storz are few of the top companies in terms of neuroendoscopy devices sales.
Neuroendoscopy devices market is fragmented in nature as multiple startups have entered the market in recent years as well as major players such as B. Braun, Karl Storz, Olympus Corporation, Stryker, Medtronic, Ackermann Instruments GmbH, Adeor Medical AG, Clarus Medical LLC, Machida Endoscope, Tonglu WANHE Medical Instrument, Hawk, Schindlerendoskopie Technologie GmbH, and others.
RECENT DEVELOPMENT:
One of Aesculap's latest additions to its neuroendoscope line was the MINOP neuroendoscope. The company subsequently consolidated its position as a major force in the neuroendoscopy devices market.
Due to its new product launch in December 2018, KARL STORZ was able to hold a strong position in neuroendoscopy with its new 4 mm endoscopic NIR/ICG fluorescence imaging system.
The system is designed to help neurosurgeons enhance minimally invasive neurosurgery techniques, therefore, the new system assisted doctors to enhance their skills in this field.
Key segments
By Surgery Type:
Intraventricular
Transcranial
Transnasal
By Device Type:
Rigid Neuroendoscopy
Flexible Neuroendoscopy
By Application:
Hospitals
Medical Research Centers
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14926
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Neuroendoscopy Devices
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
Have a Look at Related Research Reports of Healthcare
Portable Medical Devices Market Size: The overall Portable Medical Devices market is projected to expand at a CAGR of 10.7% during the forecast period by 2032
Pain Management Devices Market Sales: The global pain management devices market size reached US$ 2.2 Bn in 2021. However, with rising prevalence of various chronic diseases and growing adoption of pain management devices for relieving various types of pain, the overall pain management device sales are expected to grow at a healthy CAGR of 9% between 2022 and 2032
Diabetes Care Devices Market Share: The global diabetes care devices market size is projected to be valued at US$ 9.7 Bn in 2022 and is anticipated to reach US$ 17.87 Bn by 2032, with a rapid CAGR of 6.3% from 2022 to 2032
Retractable Needle Safety Syringes Market Type: The global retractable needle safety syringes market reached a valuation of US$ 5.49 Bn in 2021 and is likely to grow at a steady CAGR of 4.0% between 2022 and 2032, totalling around US$ 8.45 Bn by 2032
Sennosides Market Forecast: The global sennosides market size was valued at US$ 331.4 Mn in 2021 and it is expected to reach a valuation of US$ 345.0 Mn by 2022
Angiographic Catheters Market Growth: The global angiographic catheters market is likely to reach US$ 2,094.4 million by 2032, up from US$ 1,402.8 million in 2022, advancing at a CAGR of 3.7% during the forecast period
Antisense Oligonucleotides Market Trends: The global antisense oligonucleotides market is projected to amass revenue of around US$ 5,659.2 million by 2032, up from US$ 1,921.6 million in 2022 moving forward with a CAGR of 10.3% during the forecast period
Artificial Urinary Sphincter Market Value: The global artificial urinary sphincter market is anticipated to be valued at US$ 441.7 Million in 2022, forecast to grow at a CAGR of 5.2% to be valued at US$ 769.2 Million from 2022 to 2032
Antimicrobial Coated Medical Devices Market Outlook: Global antimicrobial coated medical devices market is anticipated to be valued at US$ 1,344 Million in 2022, forecast to grow at a CAGR of 13.1% to be valued at US$ 5,205.2 Million from 2022 to 2032
Veterinary Auto-Immune Therapeutics Market Analysis: The global veterinary auto-immune therapeutics market is projected to be appraised at US$ 69010.77293 million by 2032, up from US$ 41087.71686 million in 2022, advancing at a CAGR of 5.3% from 2022 to 2032
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/neuroendoscopy-devices-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
